Dr. Feng Cheng

Research Center for Public Health, Tsinghua University School of Medicine, Tsinghua

Dr. Feng Cheng is a research professor at Vanke School of Public Health and Vice Dean for student affairs at the School of Medicine, Tsinghua University. He is also a Commissioner of Degree Committee on Medicine and Biomedicine of Tsinghua University. Dr. Cheng plays important role in various international and national health committees, including Vice President of Chinese Consortium of Universities for Global Health (CCUGH), Co-chair of China-Africa Health Cooperation Roundtables and Co-chair of Global Health Group at the Initiative for U.S. – China Dialogue on Global Issues. He also serves as senior adviser for Chinese government on global health cooperation research and policy.

As an infectious disease epidemiologist with more than 30 years of experience in 13 different countries, Dr. Cheng has dedicated his whole life to advocating health quality and equity. A physician by training, he has a long history of policy-focused research in major infectious diseases and public health in China and its relevance to other countries. He has been particularly adept at working in partnership with international organizations, foreign and Chinese governments to provide an evidence base for action around some of the priority areas of public health policy.

Prior to joining Tsinghua, Dr. Cheng worked as Vice President of Global Health Strategies (GHS), Director of FHI 360 and USAID Chief of Party from 2003 to 2014, where he is responsible for country and regional program management, governments’ relationship, stakeholder engagement and communications to address diverse health needs of the poor and most vulnerable populations. Before joining FHI 360 in 2003, he was national manager and principle investigator of the largest bilateral HIV/AIDS Prevention and Care Project supported jointly by UK Department for International Development (DFID) and Chinese Ministry of Health, and located at Chinese Centre for Disease Control and Prevention (China CDC).

Research: areas of interest

Prevention and control of major infectious diseases, China’s role in global health, New Technology and Health Promotion.

Publications

• Yurim Park, Daniel Casey, Indra Joshi, Jiming Zhu, Feng Cheng. Emergence of New Disease: How Can Artificial Intelligence Help?Trends in Molecular Medicine. 2020; 26:627-629
• Junfang Xu, Anders Sönnerborg, Liangmin Gao, Peicheng Wang, Jennifer Z.H. Bouey and Feng Cheng*. Delayed Treatment for People Living with HIV in China, 2004–2016: An Analysis of An Observational Cohort.Int. J. Environ. Res. Public Health 2020, 17
• Jun-Fang Xu, Pei-Cheng Wang and Feng Cheng *. Health related behaviors among HIV-infected people who are successfully linked to care: an institutional-based cross-sectional study.Infectious Diseases of Poverty,2020,9:28
• Muhammad Zakaria, Junfang Xu, Farzana Karim and Feng Cheng*. Reproductive health communication between mother and adolescent daughter in Bangladesh: a cross-sectional study. Reproductive Health (2019) 16:114
• Yang Cheng, Feng Cheng*. China’s unique role in the field of global health. Global Health Journal.https://doi.org/10.1016/j.glohj.2019.11.004
• Junfang Xu, Brick J, Xiaoxing Fu, Chunyan Su, Feng Cheng*. Considerations in the Design and Development of Smoking Cessation Apps: Smokers Perspective in China. Journal of Medical Internet Research, 2019 | vol. 7 | iss. 10 | e12200
• Su S, Fairley CK, Mao L, Medland NA, Jing J, Cheng F, et al. Estimates of the national trend of drugs use during 2000-2030 in China: A population-based mathematical model. Addict Behav (2019) 93:65–71. 10.1016/j.addbeh.2019.01.022 – DOI
• Junfang Xu, Feng Cheng*. Time between diagnosis and initiation of antiretroviral therapy among people infected with HIV/AIDS from 2004 to 2016 in China: a retrospective database study. Lancet 2018, 392:S8, DOI: 10.1016/S0140-6736(18)32637-0
• Junfang Xu, …. Feng Cheng*. Antiretroviral Regimen Change among People Infected with HIV: Evidence from a Cross-Sectional Study in China. Global Health Journal, 2018,2(3):21-30.
• Shu Su, Limin Mao, Jinxian Zhao, Liang Chen, Jun Jing, Feng Cheng*, Lei Zhang*. Epidemics of HIV, HCV and syphilis infection among synthetic drugs only users, heroin-only users and poly-drug users in Southwest China. Scientific Reports.
• Shu Su, Lei Zhang*, Feng Cheng*, Shunxiang Li, Shifu Li, Jun Jing, Christopher Kincaid Fairley, Liang Chen, Jinxian Zhao, Limin Mao. Association between recreational drug use and sexual practices among people who inject drugs in Southwest China: a cross-sectional study. BMJ Open 2018;8:e019730. doi:10.1136/bmjopen-2017-019730
• Jing Liao, Feng Cheng, Asher Harris, Dong Xu. The new face of China’s foreign aid: where do we go from here? Lancet 2018; 392:636
• Nyi Nyi Soea, …… Feng Cheng*, et al. Should human papillomavirus vaccination target women over age 26, heterosexual men and men who have sex with men? A targeted literature review of cost-effectiveness, Human Vaccines & Immunotherapeutics, DOI: 10.1080/21645515.2018.1496878
• Xiaomeng Ma, …… Feng Cheng*, et al. Prevalence of human papillomavirus by geographical regions, sexual orientation and HIV status in China: a systematic review and meta-analysis.Sex Transm Infect 2018; 94:434–442
• Emilomo Ogbe,, Dirk Van Braeckel, Marleen Temmerman, Elin C. Larsson, Ines Keygnaert, Wilson De los Reyes Aragón, Feng Cheng, Gunta Lazdane, Diane Cooper, Simukai Shamu, Peter Gichangi, Sónia Dias, Hazel Barrett, Anne Nobels, Kaiyan Pei, Anna Galle, Tammary Esho, Lucia Knight, Hanani Tabana and Olivier Degomme. Opportunities for linking research to policy: Lessons learned from implementation research in sexual and reproductive health within the ANSER network. Health Research Policy and Systems, 2018 DOI: 10.1186/s12961-018-0397-7
• Junfang Xu, Yuqian Zhang, Chengxuan Qiu and Feng Cheng*, Global and regional economic costs of dementia: a systematic review. Lancet, 2017.Vol 390 S47. DOI: http://dx.doi.org/10.1016/S0140-6736(17)33185-9
• Junfang Xu, Zhongqiang Ming, Yuqian Zhang, Feng Cheng*. Family support, discrimination and quality of life among ART-treated HIV-infected patients: a two-year study from China. Infectious Disease of Poverty, 2017, 6 (1) :152. DOI 10.1186/s40249-017-0364-5